Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
AquaBounty Technologies, Inc.
AquaBounty Technologies Inc is a biotechnology company. The company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins.
IPO Date: January 9, 2017
Sector: Healthcare
Industry: Biotech
Market Cap: $2.52M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.14 | 3.94%
Avg Daily Range (30 D): $0.04 | 4.90%
Avg Daily Range (90 D): $0.03 | 4.33%
Institutional Daily Volume
Avg Daily Volume: .49M
Avg Daily Volume (30 D): 1.57M
Avg Daily Volume (90 D): .76M
Trade Size
Avg Trade Size (Sh.): 190
Avg Trade Size (Sh.) (30 D): 413
Avg Trade Size (Sh.) (90 D): 422
Institutional Trades
Total Inst.Trades: 125
Avg Inst. Trade: $1.52M
Avg Inst. Trade (30 D): $.52M
Avg Inst. Trade (90 D): $.52M
Avg Inst. Trade Volume: .01M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.13M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 21.76K
       
News
May 15, 2024 @ 2:20 PM
AquaBounty Technologies, Inc. (AQB) Reports Q1 Los...
Source: Zacks Equity Research
May 14, 2024 @ 1:10 PM
Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Reve...
Source: Zacks Equity Research
May 13, 2024 @ 9:10 PM
Cara Therapeutics (CARA) Reports Q1 Loss, Misses R...
Source: Zacks Equity Research
May 8, 2024 @ 9:45 PM
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, To...
Source: Zacks Equity Research
Oct 16, 2023 @ 12:47 PM
Why ContraFect Shares Are Trading Higher By Around...
Source: Lisa Levin
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-38.65 $-21.78 $-38.65
Diluted EPS $-38.65 $-21.78 $-38.65
Revenue $ M $ -.71M $ M
Gross Profit $ $ $
Net Income / Loss $ -149.19M $ -84.12M $ -149.19M
Operating Income / Loss $ -111.44M $ -48.61M $ -111.44M
Cost of Revenue $ $ $
Net Cash Flow $ -8.97M $ -.27M $ -8.97M
PE Ratio    
Splits
Oct 16, 2023:   20:1
Jan 05, 2017:   30:1